Skip to main content
. Author manuscript; available in PMC: 2016 Nov 8.
Published in final edited form as: Osteoporos Int. 2010 Aug 4;22(3):789–796. doi: 10.1007/s00198-010-1359-2

Fig. 2.

Fig. 2

Percentage of women with incident fragility fracture on treatment with bisphosphonate, by fracture type

*Other: Clinical fragility fracture excluding fractures of the spine, hip, fingers, toes, and face